Cited by 161Cancer-related Molecular PathwaysHeat shock proteins researchUbiquitin and proteasome pathways

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Inactivation of the p53-homologue p73 by the mdm2-oncoprotein

Dobbelstein, Matthias, Wienzek, Sandra, König, Claudia, Roth, Judith·1999·Oncogene

DOI 10.1038/sj.onc.1202512

Open this paper in CoChat — free account

Abstract

The p73beta protein shares structural and functional similarities with the tumor suppressor gene product p53. Both proteins activate transcription from p53-responsive promoters. p53's activity is antagonized by the mdm2 protein (also termed hdm2 in human cells). Complex formation between p53 and mdm2 results in p53's transcriptional inactivation and destabilization. Here we show that overexpression of mdm2 reduces p73beta's ability to activate transcription, too. The mdm2 protein forms a specific complex with p73beta in vitro with an efficiency comparable to p53-binding. Further, both p73beta and p53 relocalize a transport-defective mutant of mdm2 from the cytoplasm to the nucleus, arguing that complex formation occurs in vivo as well. Mutational analysis suggests that the interaction between p73beta and mdm2 follows structural principles analogous to the p53-mdm2-complex. Whereas p53 is destabilized in the presence of mdm2, the amount of intracellular p73beta was not detectably reduced by mdm2. The carboxyterminal RING finger domain of mdm2 was found to be required to reduce the intracellular abundance of p53, but it was dispensable for transcriptionally inactivating either p53 or p73beta. Our results suggest that the autoregulatory feedback loop between p53 and mdm2 also controls p73's activity, but that mdm2-mediated protein degradation is unique to p53.

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1202512

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
p53, guardian of the genome
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×
“…(Figure 3e), further supporting the concept that the p73b interacts with mdm2 in vivo as well as in vitro. mdm2 does not detectably destabilize p73 In the presence of mdm2, p53 is rapidly degraded, leading to a reduced steady-state level of the protein (Haupt et al., 1997; Kubbutat et al., 1997).”
Background
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers
Kaghad, M., Bonnet, H., Yang, A., Créancier, L., Biscan, J.-C., Valent, A., Minty, A. J., Chalon, P., Lélias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,659

Show all 40 references

Research works printed but not linked: 2

Chen J, Marechal V and Levine AJ. . 1993 Mol. Cell. Biol. 13: 4107–4114. · DOI
Dobblestein M and Roth J. . 1997 J. Gen. Virol. in press.

Sorted by citations

Themes and variations on ubiquitylation
Weissman, A. M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056563 · Cited by 1,507
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
MDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641
p73: Friend or foe in tumorigenesis
Melino, G., Laurenzi, V. D., & Vousden, K. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc861 · Cited by 554
p63 and p73: Roles in Development and Tumor Formation
Moll, U. M., & Slade, N. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.371.2.7 · Cited by 488
MDM2, an introduction.
Iwakuma, T., & Lozano, G. (2003) · PubMed · Cited by 390
p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation
Melino, G., Bernassola, F., Ranalli, M., Yee, K., Zong, W. X., Corazzari, M., Knight, R. A., Green, D. R., Thompson, C., & Vousden, K. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307469200 · Cited by 368
Molecular Mechanism of the Interaction between MDM2 and p53
Schön, O., Friedler, A., Bycroft, M., Freund, S. M. V., & Fersht, A. R. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00852-5 · Cited by 349
Regulation of p53 Function
Woods, D. B., & Vousden, K. H. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5141 · Cited by 323
Activation and activities of the p53 tumour suppressor protein
Bálint, É., & Vousden, K. H. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2128 · Cited by 315
The ubiquitin–protein ligase Itch regulates p73 stability
Rossi, M., Laurenzi, V. D., Munarriz, E. R., Green, D. R., Liu, Y., Vousden, K. H., Cesareni, G., & Melino, G. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600444 · Cited by 303
The common and distinct target genes of the p53 family transcription factors
Harms, K. L., Nozell, S. E., & Chen, X. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3304-4 · Cited by 303
Functional regulation of p73 and p63: development and cancer
Melino, G. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.10.004 · Cited by 284
ASPP1 and ASPP2: Common Activators of p53 Family Members
Bergamaschi, D., Samuels, Y., Jin, B., Duraisingham, S., Crook, T., & Lü, X. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1341-1350.2004 · Cited by 229
p53-family proteins and their regulators: hubs and spokes in tumor suppression
Collavin, L., Lunardi, A., & Sal, G. D. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.35 · Cited by 225
Cyclin G Recruits PP2A to Dephosphorylate Mdm2
Okamoto, K., Li, H., Jensen, M. R., Zhang, T., Taya, Y., Thorgeirsson, S. S., & Prives, C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00504-x · Cited by 215
A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism
Serber, Z., Lai, H. C., Yang, A., Ou, H. D., Sigal, M. S., Kelly, A. E., Darimont, B. D., Duijf, P. H. G., van Bokhoven, H., McKeon, F., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8601-8611.2002 · Cited by 205
Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
Zhang, Y., & Xiong, Y. (2001) · PubMed · Cited by 176
Autoinhibitory Regulation of p73 by ΔNp73 To Modulate Cell Survival and Death through a p73-Specific Target Element within the ΔNp73 Promoter
Nakagawa, T., Takahashi, M., Ozaki, T., Watanabe, K., Todo, S., Mizuguchi, H., Hayakawa, T., & Nakagawara, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2575-2585.2002 · Cited by 177
The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein
López-Borges, S., & Lazo, P. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203709 · Cited by 158
SIRT1 interacts with p73 and suppresses p73‐dependent transcriptional activity
Dai, J. M., Wang, Z. Y., Sun, D. C., Lin, R. X., & Wang, S. Q. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20831 · Cited by 157
E2F-1 induced apoptosis
Phillips, A. C., & Vousden, K. H. (2001) · APOPTOSIS · doi:10.1023/a:1011332625740 · Cited by 144
Oncogenes Induce and Activate Endogenous p73 Protein
Zaika, A. I., Irwin, M. S., Sansome, C., & Moll, U. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005737200 · Cited by 138
p73, a sophisticated p53 family member in the cancer world
Ozaki, T., & Nakagawara, A. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00116.x · Cited by 141
MDM2 and MDMX bind and stabilize the p53-related protein p73
Ongkeko, W. M., Wang, X. Q., Siu, W. Y., Lau, A. W. S., Yamashita, K., Harris, A. L., Cox, L. S., & Poon, R. Y. C. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80367-4 · Cited by 132
MDM2-dependent ubiquitination of nuclear and cytoplasmic P53
Yu, Z. K., Geyer, R. K., & Maki, C. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203980 · Cited by 133
p53 induces the expression of its antagonist p73ΔN, establishing an autoregulatory feedback loop
Kartasheva, N. N., Contente, A., Lenz-Stöppler, C., Roth, J. C., & Dobbelstein, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205584 · Cited by 127
Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
Adams, C. M., Mitra, R., Xiao, Y., Michener, P., Palazzo, J., Chao, A., Gour, J., Cassel, J. A., Salvino, J. M., & Eischen, C. M. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1131 · Cited by 126
Mdm2-mediated NEDD8 Modification of TAp73 Regulates Its Transactivation Function
Watson, I. R., Blanch, A., Lin, D. C. C., Ohh, M., & Irwin, M. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603654200 · Cited by 120
p53, p63 and p73 – solos, alliances and feuds among family members
Moll, U. M., Erster, S. H., & Zaika, A. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00036-1 · Cited by 114
Functional interplay between MDM2, p63/p73 and mutant p53
Stindt, M., Muller, P. A. J., Ludwig, R., Kehrloesser, S., Dötsch, V., & Vousden, K. H. (2014) · Oncogene · doi:10.1038/onc.2014.359 · Cited by 114
MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53
Wienken, M., Dickmanns, A., Nemajerová, A., Kramer, D., Najafova, Z., Weiss, M., Karpiuk, O., Kassem, M. S., Zhang, Y., Lozano, G., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.12.008 · Cited by 116
ΔNp73β Is Active in Transactivation and Growth Suppression
Liu, G., Nozell, S. E., Xiao, H., & Chen, X. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.487-501.2004 · Cited by 109
Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1
Ray, R. M., Bhattacharya, S., & Johnson, L. R. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0538-0 · Cited by 100
MDM2’s social network
Fåhræus, R., & Olivares‐Illana, V. (2013) · Oncogene · doi:10.1038/onc.2013.410 · Cited by 103
Cell cycle regulatory functions of the human oncoprotein MDM2.
Deb, S. P. (2003) · PubMed · Cited by 96
The N-Terminal Domain of p73 Interacts with the CH1 Domain of p300/CREB Binding Protein and Mediates Transcriptional Activation and Apoptosis
Zeng, X., Li, X., Miller, A., Yuan, Z.-M., Yuan, W., Kwok, R. P. S., Goodman, R. H., & Lu, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1299-1310.2000 · Cited by 97
MDM2 and MDMX can interact differently with ARF and members of the p53 family
Wang, X., Arooz, T., Siu, W. Y., Chiu, C. H. S., Lau, A., Yamashita, K., & Poon, R. Y. C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02124-x · Cited by 94
Regulation and activation of p53 and its family members
Lohrum, M. A. E., & Vousden, K. H. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400625 · Cited by 91
Expression of homologues for p53 and p73 in the softshell clam (Mya arenaria), a naturally-occurring model for human cancer
Kelley, M. L., Winge, P., Heaney, J. D., Stephens, R. E., Farrell, J. H., Beneden, R. J. V., Reinisch, C. L., Lesser, M. P., & Walker, C. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204144 · Cited by 89
From p63 to p53 across p73
Strano, S., Rossi, M., Fontemaggi, G., Munarriz, E. R., Soddu, S., Sacchi, A., & Blandino, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02119-6 · Cited by 87
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and BeyondPreprint
Marine, J., & Jochemsen, A. G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026237 · Cited by 82
Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.
Ozaki, T., Naka, M., Takada, N., Tada, M., Sakiyama, S., & Nakagawara, A. (1999) · PubMed · Cited by 78
Regulation of p63 Function by Mdm2 and MdmX
Kadakia, M., Slader, C., & Berberich, S. J. (2001) · DNA and Cell Biology · doi:10.1089/10445490152122433 · Cited by 73
Comparative Analysis of P73 and P53 Regulation and Effector Functions
Li, F., Lee, S. W., & Aaronson, S. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.4.823 · Cited by 75
Physical Interaction of p73 with c-Myc and MM1, a c-Myc-binding Protein, and Modulation of the p73 Function
Watanabe, K., Ozaki, T., Nakagawa, T., Miyazaki, K., Takahashi, M., Hosoda, M., Hayashi, S., Todo, S., & Nakagawara, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111281200 · Cited by 71
Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway
Bang, S., Kaur, S., & Kurokawa, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010261 · Cited by 69
Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway
Song, J., Ma, S., Luo, J., Zhang, H., Wang, R.-X., Liu, H., Li, L., Zhang, Z., & Zhou, R. (2018) · Oncology Reports · doi:10.3892/or.2018.6282 · Cited by 72
p63 and p73: old members of a new family
Marín, M. C., & Kaelin, W. G. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00010-x · Cited by 67
The p53 family: same response, different signals?
Chen, X. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01545-2 · Cited by 67
Analysis of p73 in human borderline and invasive ovarian tumor
Ng, S.-W., Yiu, G. K., Liu, Y., Huang, L., Palnati, M., Jun, S. H., Berkowitz, R. S., & Mok, S. C. (2000) · Oncogene · doi:10.1038/sj.onc.1203512 · Cited by 66
Murine double minute 2: p53-independent roads lead to genome instability or death
Bouska, A. C., & Eischen, C. M. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.02.006 · Cited by 68
Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73
Zdzalik, M., Pustelny, K., Kędracka–Krok, S., Huben, K., Pęcak, A., Władyka, B., Jankowski, S., Dubin, A., Potempa, J., & Dubin, G. (2010) · Cell Cycle · doi:10.4161/cc.9.22.13871 · Cited by 65
Regulation of p73 activity by post-translational modifications
Conforti, F., Sayan, E., Sreekumar, R., & Sayan, B. S. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.27 · Cited by 64
The Many Faces of MDM2 Binding Partners
Riley, M. F., & Lozano, G. (2012) · Genes & Cancer · doi:10.1177/1947601912455322 · Cited by 66
Identification of a Sequence Element from p53 That Signals for Mdm2-Targeted Degradation
Gu, J., Chen, D., Lichtenstein, J. H. R., Rubin, R. M., & Yuan, Z.-M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1243-1253.2000 · Cited by 64
Hdmx and Mdm2 can repress transcription activation by p53 but not by p63
Little, N. A., & Jochemsen, A. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204615 · Cited by 64
MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis
Li, G. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl047 · Cited by 63
Cyclin-dependent Kinases Phosphorylate p73 at Threonine 86 in a Cell Cycle-dependent Manner and Negatively Regulate p73
Gaiddon, C., Lokshin, M., Groß, I., Levasseur, D., Taya, Y., Loeffler, J., & Prives, C. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300251200 · Cited by 63
Structural diversity of p63 and p73 isoforms
Osterburg, C., & Dötsch, V. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00975-4 · Cited by 67
A possible role of p73 on the modulation of p53 level through MDM2.
Wang, X. Q., Ongkeko, W. M., Lau, A. W. S., Leung, K. M., & Poon, R. Y. C. (2001) · PubMed · Cited by 61
ΔN-p73α Accumulates in Human Neuroblastic Tumors
Douc‐Rasy, S., Barrois, M., Echeynne, M., Kaghad, M., Blanc, É., Raguénez, G., Goldschneider, D., Terrier‐Lacombe, M., Hartmann, O., Moll, U. M., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64883-3 · Cited by 58
Mdm2: A Regulator of Cell Growth and Death
Alarcon-Vargas, D., Takahashi, S., & Ronai, Z. A. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)01001-7 · Cited by 57
The roles of moonlight ribosomal proteins in the development of human cancers
Molavi, G., Samadi, N., & Hosseingholi, E. Z. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27722 · Cited by 56
MDM2 Mediates p300/CREB-binding Protein-associated Factor Ubiquitination and Degradation
Jin, Y., Zeng, S. X., Lee, H., & Lu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309916200 · Cited by 56
Protoporphyrin IX Interacts with Wild-type p53 Protein in Vitro and Induces Cell Death of Human Colon Cancer Cells in a p53-dependent and -independent Manner
Zawacka‐Pankau, J., Issaeva, N., Hossain, S., Pramanik, A., Selivanova, G., & Podhajska, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608906200 · Cited by 58
Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Δ Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51
Senoo, M., Tsuchiya, I., Matsumura, Y., Mori, T., Saito, Y., Kato, H., Okamoto, T., & Habu, S. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1735 · Cited by 55
p53 Gene Family p51(p63)-Encoded, Secondary Transactivator p51B(TAp63α) Occurs without Forming an Immunoprecipitable Complex with MDM2, but Responds to Genotoxic Stress by Accumulation
Okada, Y., Osada, M., Kurata, S., Sato, S., Aisaki, K., Kageyama, Y., Kihara, K., Ikawa, Y., & Katoh, I. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5535 · Cited by 55
Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition
Zhou, X. Y., Hao, Q., Zhang, Q., Jm, L., Jw, K., Liao, P., Cao, B., & Lu, H. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.167 · Cited by 55
Mdm2 and MdmX as Regulators of Gene Expression
Biderman, L., Manley, J. L., & Prives, C. L. (2012) · Genes & Cancer · doi:10.1177/1947601912455331 · Cited by 58
MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed–Sternberg cells: results from single‐cell polymerase chain reaction and molecular cytogenetic studies
Küpper, M., Joos, S., von Bonin, F., Daus, H., Pfreundschuh, M. G., Lichter, P., & Trümper, L. H. P. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02566.x · Cited by 55
Expression of the Cell Cycle Phosphatase cdc25C Is Down-Regulated by the Tumor Suppressor Protein p53 but Not by p73
Krause, K., Haugwitz, U., Wasner, M., Wiedmann, M. W., Mössner, J., & Engeland, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5040 · Cited by 53
Therapeutic prospects for p73 and p63: Rising from the shadow of p53
Vilgelm, A. E., El-Rifai, W. M., & Zaika, A. I. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.08.001 · Cited by 53
Transcriptional activation by the PHD finger is inhibited through an adjacent leucine zipper that binds 14-3-3 proteins
Halbach, T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.18.3542 · Cited by 53
Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways
Zheng, T., Wang, J., Song, X., Meng, X., Pan, S., Jiang, H., & Liu, L. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0817-8 · Cited by 51
MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53
Klein, A. M., Biderman, L., Tong, D., Alaghebandan, B., Plumber, S. A., Mueller, H. S., van Vlimmeren, A. E., Katz, C., & Prives, C. L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102420118 · Cited by 48
MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins.
Yam, C. H., Siu, W. Y., Arooz, T., Chiu, C. H. S., Lau, A. W. S., Wang, X. Q., & Poon, R. Y. C. (1999) · PubMed · Cited by 46
Amplification and Overexpression of mdm2 Gene in Ependymomas
Suzuki, S. O., & Iwaki, T. (2000) · Modern Pathology · doi:10.1038/modpathol.3880095 · Cited by 45
Function and dysfunction of the human oncoprotein MDM2
Deb, S. P. (2002) · Frontiers in bioscience · doi:10.2741/a723 · Cited by 45
P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
Faridoni‐Laurens, L., Bosq, J., Janot, F., Vayssade, M., Bihan, M. L., Kaghad, M., Caput, D., Bénard, J., & Ahomadegbe, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204687 · Cited by 44
TP63 and TP73 in cancer, an unresolved “family” puzzle of complexity, redundancy and hierarchy
Costanzo, A., Pediconi, N., Narcisi, A., Guerrieri, F., Belloni, L., Fausti, F., Botti, E., & Levrero, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.06.047 · Cited by 43
Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53
Chao, T., Zhou, X. Y., Cao, B., Liao, P., Liu, H., Chen, Y., Park, H., Zeng, S. X., & Lu, H. (2016) · Nature Communications · doi:10.1038/ncomms13755 · Cited by 43
p300 Does Not Require Its Acetylase Activity to Stimulate p73 Function
Zeng, X., Lee, H., Zhang, Q., & Lu, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000722200 · Cited by 46
Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model
Tonsing-Carter, E., Bailey, B. J., Saadatzadeh, M. R., Ding, J., Wang, H., Sinn, A. L., Peterman, K. M., Spragins, T. K., Silver, J. M., Sprouse, A. A., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0237 · Cited by 42
p73 Is Regulated by Phosphorylation at the G2/M Transition
Fulco, M., Costanzo, A., Merlo, P., Mangiacasale, R., Strano, S., Blandino, G., Balsano, C., Lavia, P., & Levrero, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304921200 · Cited by 42
Targeting p73 in cancer
Maas, A.-M., Bretz, A. C., Mack, E., & Stiewe, T. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.030 · Cited by 43
Cyclin D1 protein expression and gene polymorphism in colorectal cancer
McKay, J., Douglas, J. J., Ross, V. G., Curran, S., Murray, G. I., Cassidy, J., & Initiative, O. B. O. T. A. C. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001001)88:1 · Cited by 121
MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase varepsilon
Vlatković, N. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.18.3581 · Cited by 40
Non-substituted N-heteroaromatic selenosemicarbazone metal complexes induce apoptosis in cancer cells via activation of mitochondrial pathway
Srdić‐Rajić, T., Zec, M. M., Todorović, T. R., Anđelković, K., & Radulovic, S. S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.05.039 · Cited by 39
Mdm2: Open questions
Dobbelstein, M., & Levine, A. J. (2020) · Cancer Science · doi:10.1111/cas.14433 · Cited by 40
p73 as a Pharmaceutical Target for Cancer Therapy
Bisso, A., Collavin, L., & Sal, G. D. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795222667 · Cited by 41
ΔNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation
Slade, N., Zaika, A. I., Erster, S. H., & Moll, U. M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401335 · Cited by 39
Regulation of p63 Protein Stability via Ubiquitin-Proteasome Pathway
Li, C., & Xiao, Z. J. (2014) · BioMed Research International · doi:10.1155/2014/175721 · Cited by 36
Failure of viral oncoproteins to target the p53-homologue p51A
Roth, J. C., & Dobbelstein, M. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-12-3251 · Cited by 36
Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B
Martín, Á. G., Trama, J. P., Crighton, D., Ryan, K. M., & Fearnhead, H. O. (2009) · Aging · doi:10.18632/aging.100026 · Cited by 35
Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line
Goldschneider, D., Blanc, É., Raguénez, G., Barrois, M., Legrand, A., Roux, G. L., Haddada, H., Bénard, J., & Douc‐Rasy, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00834 · Cited by 34
p53 Family in Resistance to Targeted Therapy of Melanoma
Vlašić, I., Horvat, A., Tadijan, A., & Slade, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010065 · Cited by 36
p73: From the p53 shadow to a major pharmacological target in anticancer therapy
Ramos, H., Raimundo, L., & Saraiva, L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105245 · Cited by 33
MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression
Giansanti, C., Manzini, V., Dickmanns, A., Dickmanns, A., Palumbieri, M. D., Sanchi, A., Kienle, S. M., Rieth, S., Scheffner, M., Lopes, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110879 · Cited by 34
Characterization and Role of p53 Family Members in the Symbiont-Induced Morphogenesis of theEuprymna scolopesLight Organ
Goodson, M. S., Crookes‐Goodson, W. J., Kimbell, J. R., & McFall‐Ngai, M. (2006) · Biological Bulletin · doi:10.2307/4134573 · Cited by 31

Authors: Dobbelstein, M., Wienzek, S., König, C., & Roth, J.
Affiliations: Philipps University of Marburg (DE)
ORCID: Dobbelstein, Matthias
Venue: Oncogene
Publisher: Springer Science and Business Media LLC
Published: 1999-03-25
Volume: 18
Issue: 12
Pages: 2101-2106
ISSN: 0950-9232 (ISSN-L)
1476-5594
DOI: 10.1038/sj.onc.1202512
OpenAlex: W2312957642
Cited by: 161
References: 40
Citations by year: 2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 6 · 2014: 6 · 2013: 4 · 2012: 5
FWCI: 7.98
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Oncogene (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords: p53, MDM2, transcriptional inactivation, protein-protein interaction, RING domain, protein degradation, autoregulatory loop, tumor suppressor proteins, nuclear translocation
MeSH terms: Tumor Protein p73, Biological Transport, Cell Compartmentation, Cell Nucleus, Cytoplasm, DNA-Binding Proteins, Nuclear Proteins, Protein Binding, Proto-Oncogene Proteins, Transcription Factors, Transcriptional Activation, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, Tumor Suppressor Proteins, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inactivation of the p53-homologue p73 by the mdm2-oncoprotein

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks